Bank Of America Corp Werewolf Therapeutics, Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 2,147,425 shares of HOWL stock, worth $4.85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,147,425

Previous 1,881,113 14.16%

Holding current value

$4.85 Million

Previous $12.2 Million 57.02%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.34 - $6.75 $623,170 - $1.8 Million	266,312 Added 14.16%	2,147,425 $5.24 Million
Q1 2024 May 15, 2024	SELL	$3.92 - $7.91 $842,674 - $1.7 Million	-214,968 Reduced 10.26%	1,881,113 $12.2 Million
Q4 2023 Feb 14, 2024	BUY	$1.78 - $4.15 $1.01 Million - $2.35 Million	566,226 Added 37.01%	2,096,081 $8.09 Million
Q2 2023 Aug 14, 2023	SELL	$2.31 - $3.65 $3,714 - $5,869	-1,608 Reduced 0.1%	1,529,855 $4.67 Million
Q1 2023 May 12, 2023	SELL	$1.98 - $4.3 $4,215 - $9,154	-2,129 Reduced 0.14%	1,531,463 $3.98 Million
Q4 2022 Feb 10, 2023	BUY	$1.53 - $4.73 $2.34 Million - $7.24 Million	1,530,114 Added 43994.08%	1,533,592 $3.14 Million
Q3 2022 Nov 14, 2022	BUY	$4.14 - $7.42 $3,245 - $5,817	784 Added 29.1%	3,478 $15,000
Q2 2022 Aug 12, 2022	SELL	$3.43 - $5.98 $67,306 - $117,345	-19,623 Reduced 87.93%	2,694 $11,000
Q1 2022 May 16, 2022	SELL	$3.71 - $12.22 $22,067 - $72,684	-5,948 Reduced 21.04%	22,317 $98,000
Q4 2021 Feb 08, 2022	BUY	$11.48 - $17.65 $317,376 - $487,951	27,646 Added 4466.24%	28,265 $337,000
Q3 2021 Nov 15, 2021	BUY	$13.89 - $20.31 $1,833 - $2,680	132 Added 27.1%	619 $11,000
Q2 2021 Sep 13, 2021	BUY	$11.6 - $17.44 $5,649 - $8,493	487 New	487 $8,000

Others Institutions Holding HOWL

# of Institutions

Shares Held

32.1M

Call Options Held

53.8K

Put Options Held

1.3K

View Full List

About Werewolf Therapeutics, Inc.

Ticker HOWL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,529,400
Market Cap $66.7M
Description
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...

More about HOWL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Werewolf Therapeutics, Inc. Transaction History